GB8412862D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB8412862D0
GB8412862D0 GB848412862A GB8412862A GB8412862D0 GB 8412862 D0 GB8412862 D0 GB 8412862D0 GB 848412862 A GB848412862 A GB 848412862A GB 8412862 A GB8412862 A GB 8412862A GB 8412862 D0 GB8412862 D0 GB 8412862D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB848412862A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB848412862A priority Critical patent/GB8412862D0/en
Publication of GB8412862D0 publication Critical patent/GB8412862D0/en
Priority to EP85105848A priority patent/EP0171519A3/en
Priority to ES543264A priority patent/ES8703441A1/es
Priority to ZA853732A priority patent/ZA853732B/xx
Priority to AU42606/85A priority patent/AU4260685A/en
Priority to DK220885A priority patent/DK220885A/da
Priority to GR851208A priority patent/GR851208B/el
Priority to US06/735,357 priority patent/US4593023A/en
Priority to JP60106802A priority patent/JPS60255781A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB848412862A 1984-05-19 1984-05-19 Compounds Pending GB8412862D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB848412862A GB8412862D0 (en) 1984-05-19 1984-05-19 Compounds
EP85105848A EP0171519A3 (en) 1984-05-19 1985-05-13 6-oxomorpholine derivatives, process for their preparation, intermediates, and pharmaceutical compositions containing these derivatives
ES543264A ES8703441A1 (es) 1984-05-19 1985-05-17 Un procedimiento para la preparacion de agentes anti-hiperglicemicos de lactona.
ZA853732A ZA853732B (en) 1984-05-19 1985-05-17 Lactone hyperglycaemic agents
AU42606/85A AU4260685A (en) 1984-05-19 1985-05-17 Phenylalkyl substituted 2-phenyl-morpholino compounds
DK220885A DK220885A (da) 1984-05-19 1985-05-17 Lactoner
GR851208A GR851208B (en:Method) 1984-05-19 1985-05-17
US06/735,357 US4593023A (en) 1984-05-19 1985-05-17 6-oxomorpholines
JP60106802A JPS60255781A (ja) 1984-05-19 1985-05-18 ラクトン誘導体、その製法及びそれを含む医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848412862A GB8412862D0 (en) 1984-05-19 1984-05-19 Compounds

Publications (1)

Publication Number Publication Date
GB8412862D0 true GB8412862D0 (en) 1984-06-27

Family

ID=10561226

Family Applications (1)

Application Number Title Priority Date Filing Date
GB848412862A Pending GB8412862D0 (en) 1984-05-19 1984-05-19 Compounds

Country Status (9)

Country Link
US (1) US4593023A (en:Method)
EP (1) EP0171519A3 (en:Method)
JP (1) JPS60255781A (en:Method)
AU (1) AU4260685A (en:Method)
DK (1) DK220885A (en:Method)
ES (1) ES8703441A1 (en:Method)
GB (1) GB8412862D0 (en:Method)
GR (1) GR851208B (en:Method)
ZA (1) ZA853732B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT86919B (pt) * 1987-03-10 1992-05-29 Beecham Group Plc Metodo para a utilizacao de derivados de morfolina em medicina e agricultura e respectivo processo de preparacao
WO1988009661A1 (en) * 1987-06-10 1988-12-15 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
YU15500A (sh) * 1999-03-30 2002-03-18 Pfizer Products Inc. Postupak za dobijanje cikličnih tioamida

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2096988B (en) * 1980-11-20 1984-08-01 Beecham Group Ltd Aromatic hydroxyamines
DE3476386D1 (de) * 1983-11-02 1989-03-02 Beecham Group Plc Morpholine derivatives

Also Published As

Publication number Publication date
DK220885D0 (da) 1985-05-17
AU4260685A (en) 1985-11-21
US4593023A (en) 1986-06-03
ES8703441A1 (es) 1987-02-16
ZA853732B (en) 1986-04-30
ES543264A0 (es) 1987-02-16
EP0171519A2 (en) 1986-02-19
DK220885A (da) 1985-11-20
JPS60255781A (ja) 1985-12-17
EP0171519A3 (en) 1989-01-04
GR851208B (en:Method) 1985-11-25

Similar Documents

Publication Publication Date Title
DE3569932D1 (en) Cotelomer compounds
GB8404584D0 (en) Compounds
GB8404586D0 (en) Compounds
GB8417171D0 (en) Compounds
GB8415540D0 (en) Imidazoisoquinoline compounds
GB8415377D0 (en) Compounds
GB8418657D0 (en) Compounds
GB8406689D0 (en) Compounds
GB8402086D0 (en) Compounds
GB8412862D0 (en) Compounds
GB8419103D0 (en) Compounds
GB8401868D0 (en) Compounds
GB8407708D0 (en) Compounds
GB8414457D0 (en) Compounds
GB8404585D0 (en) Compounds
GB8403464D0 (en) Compounds
GB8404587D0 (en) Compounds
GB8404588D0 (en) Compounds
GB8405955D0 (en) Compounds
GB8403463D0 (en) Compounds
GB8407024D0 (en) Compounds
GB8415376D0 (en) Compounds
GB8408322D0 (en) Compounds
GB8403004D0 (en) Compounds
GB8409987D0 (en) Compounds